A carregar...
Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation
Na minha lista:
| Formato: | Artigo |
|---|---|
| Idioma: | en |
| Publicado em: |
Yonsei University College of Medicine
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5368161/ https://ncbi.nlm.nih.gov/pubmed/28332381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.3.679 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|